⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADPT News
Adaptive Biotechnologies Corporation Common Stock
Form 8-K
sec.gov
ADPT
Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
globenewswire.com
ADPT
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
globenewswire.com
ADPT
Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial
globenewswire.com
ADPT
IVDA
Form 8-K
sec.gov
ADPT
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
globenewswire.com
ADPT
Form 8-K
sec.gov
ADPT
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
globenewswire.com
ADPT
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
globenewswire.com
ADPT
Form 8-K
sec.gov
ADPT